These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34980714)

  • 1. Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease.
    A Al-Samhari G; M Al-Mushiki G; Tamrakar R; Abdullahi G; Lin YD; Tang XY
    J Nutr Sci Vitaminol (Tokyo); 2021; 67(6):366-374. PubMed ID: 34980714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
    Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
    Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)].
    Ait Boudaoud A; Rives-Lange C; Perregaux JF; Radu A; Messager-Josipowicz D; Barsamian C; Carette C; Czernichow S
    Presse Med; 2019 Dec; 48(12):1496-1501. PubMed ID: 31757727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review.
    Castillo MF; Salgado-Canales D; Arrese M; Barrera F; Mikhailidis DP
    Curr Vasc Pharmacol; 2024; 22(3):187-202. PubMed ID: 38321893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.
    Worm N
    Nutrients; 2020 May; 12(5):. PubMed ID: 32384593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
    Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide.
    Aboubakr A; Stroud A; Kumar S; Newberry C
    Curr Gastroenterol Rep; 2021 Oct; 23(12):21. PubMed ID: 34654976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.
    Rinaldi R; De Nucci S; Castellana F; Di Chito M; Giannuzzi V; Shahini E; Zupo R; Lampignano L; Piazzolla G; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
    Cui H; Zhang X
    J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD.
    Schübel R; Nonnenmacher T; Sookthai D; Gonzalez Maldonado S; Sowah SA; von Stackelberg O; Schlett CL; Grafetstätter M; Nabers D; Johnson T; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Kühn T; Nattenmüller J
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30836637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
    Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
    World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
    Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
    Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonalcoholic Fatty Liver Disease and Weight Loss].
    Ping F; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Oct; 40(5):597-602. PubMed ID: 30404689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.